BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
DNA fingerprint
,
Rapamycin
,
rs2230926
,
PTEN
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
interleukin 31
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Juvenile idiopathic arthritis
Smoker
Pneumonia
Clostridial enteric disease
Middle East respiratory syndrome
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
MSLN protein, human
Leptin
TNFRSF17 protein, human
Enterotoxins
Ionomycin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FAM110B
DAZAP1
UBB
FGF3
AIRE
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
IL-31 induces antitumor immunity in breast carcinoma.
IL-31 transgenic mice show reduced allergen-induced lung inflammation.
Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound.
Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma.
Correlation of serum interleukin-31 with pruritus and blood eosinophil markers in children with atop…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in He…
Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria
Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy
Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica
Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ